Jun 30, 2020

Acacia Q2 2020 Earnings Report

Reported second quarter results, highlighted by the acquisition of the Woodford portfolio and subsequent asset sales.

Key Takeaways

Acacia Research Corporation reported their second quarter 2020 financial results, featuring the acquisition of the Woodford portfolio of life science assets for $282 million and the recovery of $185 million through sales of certain acquired assets. The company's book value at June 30 is $164.7 million, or $3.36 per share.

Acquired Woodford portfolio of life science assets for $282 million.

Recovered $185 million to date in sales of certain acquired assets.

Positions include a 6% stake in Oxford Nanopore and a 5% stake in Immunocore.

Current book value at June 30 is $164.7 million, or $3.36 per share.

Total Revenue
$2.12M
Previous year: $5.46M
-61.2%
EPS
$0.09
Previous year: -$0.04
-325.0%
Gross Profit
-$1.23M
Previous year: -$211K
+482.5%
Cash and Equivalents
$164M
Previous year: $63.5M
+158.8%
Free Cash Flow
-$4.92M
Previous year: -$64.1M
-92.3%
Total Assets
$394M
Previous year: $204M
+93.4%

Acacia

Acacia

Forward Guidance

Acacia intends to commence a Stockholder Offering of up to $31.5 million of senior secured notes, and warrants to purchase shares of common stock, to existing holders of our common stock, with substantially similar terms as the Senior Secured Notes and Series B warrant issued to Starboard